Toyonaka-city, Japan Clinical Trials

A listing of Toyonaka-city, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Study of Poziotinib in Japanese Patients With NSCLC

A Phase 1/2, open-label, multicenter study to determine dose, tolerability, safety and efficacy of poziotinib in Japanese patients non-small cell lung cancer (NSCLC).

EGFR
lung carcinoma
metastasis
systemic therapy
HER2
Osaka City General Hospital
 (6.0 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +5 other locations
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With R/R B-NHL

The purpose of the trial is to determine the maximum tolerated dose and/or the recommended phase 2 dose as well as to establish the safety profile of epcoritamab in Japanese patients with Relapsed, Progressive or Refractory B-Cell Lymphomas.

diffuse large b-cell lymphoma
monoclonal antibodies
b-cell lymphoma
large b-cell lymphoma
measurable disease
Osaka University Hospital
 (4.1 away) Contact site
  • 0 views
  • 24 May, 2021
  • +20 other locations
A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF) Post-polycythemia Vera Myelofibrosis (Post-PV MF) or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

The study will be conducted in compliance with the International Council for Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This is a Phase 1/2 multicenter, single arm, open-label study in Japanese subjects with DIPSS intermediate or high-risk PMF, …

Osaka City University Hospital
 (9.5 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +15 other locations